Bank of New York Mellon’s Evolus EOLS Stock Holding History

Bank of New York Mellon’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Buy	162,849 +19,685	+14%	+$116K	﹤0.01%	3289
2026 Q1	$588K	Buy	143,164 +5,367	+4%	+$26K	﹤0.01%	3521
2025 Q4	$916K	Sell	137,797 -5,023	-4%	-$34K	﹤0.01%	3291
2025 Q3	$877K	Buy	142,820 +1,815	+1%	+$14.2K	﹤0.01%	3283
2025 Q2	$1.3M	Buy	141,005 +5,300	+4%	+$54.2K	﹤0.01%	2976
2025 Q1	$1.63M	Sell	135,705 -894	-0.7%	-$11.7K	﹤0.01%	2785
2024 Q4	$1.51M	Buy	136,599 +13	+0%	+$183	﹤0.01%	2894
2024 Q3	$2.21M	Sell	136,586 -44,507	-25%	-$622K	﹤0.01%	2700
2024 Q2	$1.96M	Buy	181,093 +35,760	+25%	+$440K	﹤0.01%	2800
2024 Q1	$2.03M	Sell	145,333 -16,750	-10%	-$218K	﹤0.01%	2751
2023 Q4	$1.71M	Sell	162,083 -1,937	-1%	-$17.3K	﹤0.01%	2908
2023 Q3	$1.5M	Buy	164,020 +17,999	+12%	+$161K	﹤0.01%	2958
2023 Q2	$1.06M	Buy	146,021 +22,473	+18%	+$194K	﹤0.01%	3164
2023 Q1	$1.05M	Buy	123,548 +1,285	+1%	+$11.6K	﹤0.01%	3114
2022 Q4	$918K	Sell	122,263 -15	-0%	-$116	﹤0.01%	3229
2022 Q3	$983K	Sell	122,278 -39,248	-24%	-$416K	﹤0.01%	3210
2022 Q2	$1.87M	Buy	161,526 +54,500	+51%	+$643K	﹤0.01%	2867
2022 Q1	$1.2M	Buy	107,026 +1,472	+1%	+$12.5K	﹤0.01%	3199
2021 Q4	$688K	Buy	105,554 +1,847	+2%	+$12.7K	﹤0.01%	3599
2021 Q3	$791K	Buy	103,707 +16,624	+19%	+$172K	﹤0.01%	3540
2021 Q2	$1.1M	Buy	87,083 +10,981	+14%	+$121K	﹤0.01%	3348
2021 Q1	$988K	Sell	76,102 -419	-0.5%	-$3.86K	﹤0.01%	3335
2020 Q4	$257K	Sell	76,521 -7,020	-8%	-$26.4K	﹤0.01%	3885
2020 Q3	$326K	Sell	83,541 -1,084	-1%	-$3.96K	﹤0.01%	3696
2020 Q2	$449K	Buy	84,625 +2,682	+3%	+$12.4K	﹤0.01%	3535
2020 Q1	$341K	Sell	81,943 -1,138	-1%	-$9.64K	﹤0.01%	3545
2019 Q4	$1.01M	Buy	83,081 +33,310	+67%	+$470K	﹤0.01%	3242
2019 Q3	$778K	Buy	49,771 +9,135	+22%	+$150K	﹤0.01%	3305
2019 Q2	$594K	Sell	40,636 -15,677	-28%	-$311K	﹤0.01%	3518
2019 Q1	$1.27M	Buy	56,313 +26,371	+88%	+$570K	﹤0.01%	3023
2018 Q4	$356K	Buy	29,942 +9,575	+47%	+$137K	﹤0.01%	3643
2018 Q3	$379K	Buy	20,367 +5,005	+33%	+$108K	﹤0.01%	3755
2018 Q2	$430K	Buy	+15,362	New	+$271K	﹤0.01%	3694

Other funds holding EOLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

AWM

Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Bank of New York Mellon's EOLS Position: Q2 2026 in Review

Bank of New York Mellon increased its Evolus (EOLS) stake by 14% in Q2 2026, buying an estimated $116K and bringing the position to 162,849 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3289.

Bank of New York Mellon first reported a position in EOLS in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.21M in Q3 2024. 66 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

Bank of New York Mellon held 162,849 shares of Evolus worth $1.13M as of Q2 2026.
Bank of New York Mellon bought 19,685 Evolus shares in Q2 2026, an estimated $116K.
Evolus made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3289 holding.
Bank of New York Mellon first reported a position in Evolus in Q2 2018 and has held it in 33 quarters since.
Bank of New York Mellon's Evolus position peaked at $2.21M in Q3 2024.
66 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.